"","submission_name","submission_date","template_name","tissue_type","response_component_original","response_comp_orig_cnt","response_component","response_comp_cnt","cell_ontology_id","proterm_and_extra","pro_ontology_id","fully_qualified_response_component","response_behavior_type","response_behavior","subgroup","time_point","time_point_units","baseline_time","target_pathogen","vaccine_year","exposure_material_text","exposure_material","additional_exposure_material","comparison","cohort","adjuvant","route","publication_reference","publication_year","signature_source","signature_source_url","comments","publication_reference_url","age_group","age_min","age_max","age_units","subm_obs_id","uniq_obs_id","row_key","signature_file"
"subject","","","","cell_subset","","","cell_subset","","","","","","","","","","","","pathogen","","","vaccine","","","","","","","","","","","","","","","","","","",""
"evidence","","","","","label","label","","label","label","label","label","label","label","label","label","label","label","label","","label","label","","label","label","label","label","label","label","label","label","label","label","url","label","label","label","label","label","label","label","file"
"role","","","","tissue","observed","observed","cell_biomarker","observed","observed","observed","observed","observed","background","measured","background","observed","observed","background","pathogen","background","background","vaccine","background","background","observed","background","background","background","background","background","background","background","reference","observed","observed","observed","observed","background","background","background","observed"
"mime_type","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",""
"numeric_units","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",""
"display_text","","","","tissue type","response component (original cell type)","response component (original) count","response component (cell subset)","response component count","cell ontology ID","cell type PRO and extra terms","protein ontology ID","all response components in signature","response behavior type","response behavior","subgroup","time point","time point units","baseline time","target pathogen","vaccine year","exposure material (name)","exposure material (VO)","additional exposure material","comparison","cohort","adjuvant","route","publication reference (PMID)","publication year","signature source figure, table or text section","signature source url","comments and additional details","Sobolev et al. (2016) Adjuvanted influenza-H1N1 vaccination reveals lymphoid signatures of age-dependent early responses and of clinical adverse events. Nat Immunol PMID: <a href = 'https://www.ncbi.nlm.nih.gov/pubmed/?term=26726811' target='_blank'>26726811</a>","cohort","min. age","max. age","age units","ID of observation within its own submission","Uniq ID of observation within its submission type","row key","signature response component (cell types) file"
"","hipc_ctf_26726811_19","2016.02","hipc_ctf_26726811_19","peripheral blood mononuclear cell","CD45RO+ CCR7+ central memory CD4 cells","2","central memory CD4-positive, alpha-beta T cell","2","CL_0000904","& CD45RO+, CCR7+","PR_000001017, PR_000001203","central memory CD4-positive, alpha-beta T cell & CD45RO+, CCR7+","cell type frequency","up","none","63","days","time of vaccination (first dose)","influenza A virus (A/California/7/2009(H1N1))","","Pandemrix (A/California/7/09 (H1N1))","VO_0000410","","<35yr old vs >35yr old","adults (18-64)","AS03 (GSK)","","26726811","2016","Suppl Fig 5C","<a href = 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6485475/#SM' target='_blank'>#SM</a>","- roughly 60/40 female:male ratio, over 70% were Causasian","https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6485475/","adults, seniors","18","64","years","19","190","26726811_19_190","hipc_ctf_sig_26726811_19.txt"
"","hipc_ctf_26726811_19","2016.02","hipc_ctf_26726811_19","peripheral blood mononuclear cell","CD45RO+ CCR7+ central memory CD8 cells","2","central memory CD8-positive, alpha-beta T cell","2","CL_0000907","& CD45RO+, CCR7+","PR_000001017, PR_000001203","central memory CD8-positive, alpha-beta T cell & CD45RO+, CCR7+","cell type frequency","up","none","63","days","time of vaccination (first dose)","influenza A virus (A/California/7/2009(H1N1))","","Pandemrix (A/California/7/09 (H1N1))","VO_0000410","","<35yr old vs >35yr old","adults (18-64)","AS03 (GSK)","","26726811","2016","Suppl Fig 5C","<a href = 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6485475/#SM' target='_blank'>#SM</a>","- roughly 60/40 female:male ratio, over 70% were Causasian","https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6485475/","adults, seniors","18","64","years","19","190","26726811_19_190","hipc_ctf_sig_26726811_19.txt"
